For treatment of: Klacid It is used sinusitis, pharyngitis, pneumonia, bronchitis, erysipelas, skin and soft tissue infections.Klacid - clarithromycin
- For the treatment of organs: respiratory system, skin.
- Appointment: sinusitis, pharyngitis, pneumonia, bronchitis, erysipelas, skin and soft tissue infections.
- Indications for use:
Treatment of infectious and inflammatory diseases caused by clarithromycin-sensitive pathogens: upper respiratory tract and ENT infections (tonsillopharyngitis, otitis media, acute sinusitis); lower respiratory tract infections (acute bronchitis, exacerbation of chronic bronchitis, community-acquired bacterial and atypical pneumonia); odontogenic infections; skin and soft tissue infections; mycobacterial infections (M. avium complex, M. kansasii, M. marinum, M. leprae) and their prevention in AIDS patients; eradication of Helicobacter pylori in patients with duodenal or gastric ulcer (only in combination therapy).
A history of prolongation of the QT interval, ventricular arrhythmia or ventricular tachycardia of the "pirouette" type; hypokalemia (risk of prolongation of the QT interval); severe liver failure occurring simultaneously with renal failure; cholestatic jaundice/hepatitis in the anamnesis, developed with the use of clarithromycin; porphyria; I trimester of pregnancy; lactation (breastfeeding); simultaneous administration clarithromycin with astemizole, CISAPRIDE, pimozide, terfenadine; with ergot alkaloids, for example, ergotamine, dihydroergotamine; with midazolam for oral administration; with HMG-COA reductase inhibitors (statins), which are largely metabolized by the CYP3A4 isoenzyme (lovastatin, simvastatin), with colchicine; with ticagrelor or ranolazine; hypersensitivity to clarithromycin and other macrolides.
Active substance: clarithromycin – 500 mg.
Excipients: citric acid anhydrous – 128 mg, sodium alginate – 120 mg, sodium calcium alginate – 15 mg, lactose monohydrate – 115 mg, povidone K30 – 30 mg, talc – 30 mg, stearic acid – 21 mg, magnesium stearate – 10 mg.